Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial

被引：0
|
作者：
Concepción Payares-Herrera
María E. Martínez-Muñoz
Inés Lipperheide Vallhonrat
Rosa Malo de Molina
Manuel Pérez Torres
Andrea Trisan
Isabel Salcedo de Diego
Rosalía Alonso
Rocío Zafra
Trinidad Donaire
Rocío Sánchez
Juan José Rubio
Rafael F. Duarte Palomino
Cristina Avendaño Solá
机构：
[1] Hospital Universitario Puerta de Hierro,Department of Clinical Pharmacology
[2] Hospital Universitario Puerta de Hierro,Department of Haematology and Cell Production Unit
[3] Hospital Universitario Puerta de Hierro,Department of Intensive Care Medicine
[4] Hospital Universitario Puerta de Hierro,Department of Respiratory Medicine
来源：
Trials | / 22卷
关键词：
COVID-19; randomised controlled trial; protocol; acute respiratory distress syndrome; mesenchymal stromal cells;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial
    Fatemeh Sadat Hosseini
    Alireza Malektojari
    Sara Ghazizadeh
    Mehdi Hassaniazad
    Parivash Davoodian
    Habib Dadvand
    Amin Reza Nikpoor
    Sara Nikoofal-Sahlabadi
    Sara Kahoori
    Mojtaba Sepandi
    Soheil Hassanipour
    Mohammad Fathalipour
    Trials, 22
  • [32] Evaluation of the efficacy and safety of Melatonin in moderately ill patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial
    Ziaei, Ava
    Davoodian, Parivash
    Dadvand, Habib
    Safa, Omid
    Hassanipour, Soheil
    Omidi, Mahmoud
    Masjedi, Moein
    Mahmoudikia, Fahime
    Rafiee, Bahareh
    Fathalipour, Mohammad
    TRIALS, 2020, 21 (01)
  • [33] Evaluation of the efficacy and safety of Melatonin in moderately ill patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial
    Ava Ziaei
    Parivash Davoodian
    Habib Dadvand
    Omid Safa
    Soheil Hassanipour
    Mahmoud Omidi
    Moein Masjedi
    Fahime Mahmoudikia
    Bahareh Rafiee
    Mohammad Fathalipour
    Trials, 21
  • [34] The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial
    Hosseini, Fatemeh Sadat
    Malektojari, Alireza
    Ghazizadeh, Sara
    Hassaniazad, Mehdi
    Davoodian, Parivash
    Dadvand, Habib
    Nikpoor, Amin Reza
    Nikoofal-Sahlabadi, Sara
    Kahoori, Sara
    Sepandi, Mojtaba
    Hassanipour, Soheil
    Fathalipour, Mohammad
    TRIALS, 2021, 22 (01)
  • [35] Evaluation of the efficacy and safety of recombinant erythropoietin on the improvement of hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial
    Hamid Reza Samimagham
    Mehdi Hassani Azad
    Dariush Hooshyar
    Maryam Haddad
    Mohsen Arabi
    Mitra KazemiJahromi
    Trials, 22
  • [36] Evaluation of the efficacy and safety of recombinant erythropoietin on the improvement of hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial
    Samimagham, Hamid Reza
    Azad, Mehdi Hassani
    Hooshyar, Dariush
    Haddad, Maryam
    Arabi, Mohsen
    KazemiJahromi, Mitra
    TRIALS, 2021, 22 (01)
  • [37] The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19
    Atmowihardjo, Leila
    Schippers, Job R.
    Bartelink, Imke H.
    Bet, Pierre M.
    van Rein, Nienke
    Purdy, Keith
    Cavalla, David
    Comberiati, Valerie
    McElroy, Andrew
    Snape, Sue D.
    Bogaard, Harm Jan
    Heunks, Leo
    Juffermans, Nicole
    Schultz, Marcus
    Tuinman, Pieter R.
    Bos, Lieuwe D. J.
    Aman, Jurjan
    TRIALS, 2022, 23 (01)
  • [38] The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19
    Leila Atmowihardjo
    Job R. Schippers
    Imke H. Bartelink
    Pierre M. Bet
    Nienke van Rein
    Keith Purdy
    David Cavalla
    Valérie Comberiati
    Andrew McElroy
    Sue D. Snape
    Harm Jan Bogaard
    Leo Heunks
    Nicole Juffermans
    Marcus Schultz
    Pieter R. Tuinman
    Lieuwe D. J. Bos
    Jurjan Aman
    Trials, 23
  • [39] An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trial
    James H. McMahon
    Jillian S. Y. Lau
    Janine Roney
    Benjamin A. Rogers
    Jason Trubiano
    Joseph Sasadeusz
    James S. Molton
    Bradley Gardiner
    Sue J. Lee
    Jennifer F. Hoy
    Allen Cheng
    Anton Y. Peleg
    Trials, 21
  • [40] An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trial
    McMahon, James H.
    Lau, Jillian S. Y.
    Roney, Janine
    Rogers, Benjamin A.
    Trubiano, Jason
    Sasadeusz, Joseph
    Molton, James S.
    Gardiner, Bradley
    Lee, Sue J.
    Hoy, Jennifer F.
    Cheng, Allen
    Peleg, Anton Y.
    TRIALS, 2020, 21 (01)
12345